No related posts.


When Writing About Antisemitism Proves the Point: What the Replies Reveal
Acting on Antisemitism: If This Was Always Possible, Why Didn’t It Happen Sooner?
Setting Canada’s AI Policy Priorities: My Appearance Before the Standing Committee on Industry, Science and Technology
The Law Bytes Podcast, Episode 262: Zack Shapiro on the Claude AI Native Law Firm
The Online Streaming Act in Jeopardy: U.S. Takes Aim at the CUSMA Cultural Exemption With Threats of Bill C-11 Retaliation
Michael Geist
mgeist@uottawa.ca
This web site is licensed under a Creative Commons License, although certain works referenced herein may be separately licensed.
deliberately adding cost to health care
is precisely why Canada should not enter into this agreement. Also, the lack of transparency in the deal is troubling. Just whom, other multinational pharmaceutical companies and myopic French farmers, is this agreement benefiting? Why would we enter such a costly agreement especially when both federal and provincial levels of government are running large deficits? The government needs to answer those question directly.